| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10013972 | HBV | ENSG00000069535.14 | protein_coding | MAOB | No | No | 4129 | P27338 |
| TVIS20025210 | HPV | ENSG00000069535.14 | protein_coding | MAOB | No | No | 4129 | P27338 |
| TVIS20068158 | HPV | ENSG00000069535.14 | protein_coding | MAOB | No | No | 4129 | P27338 |
| TVIS20064192 | HPV | ENSG00000069535.14 | protein_coding | MAOB | No | No | 4129 | P27338 |
| TVIS20020700 | HPV | ENSG00000069535.14 | protein_coding | MAOB | No | No | 4129 | P27338 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | MAOB |
|---|---|
| DrugBank ID | DB06654 |
| Drug Name | Safinamide |
| Target ID | BE0002196 |
| UniProt ID | P27338 |
| Regulation Type | antagonist |
| PubMed IDs | 15082032; 15563241 |
| Citations | Marzo A, Dal Bo L, Monti NC, Crivelli F, Ismaili S, Caccia C, Cattaneo C, Fariello RG: Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity. Pharmacol Res. 2004 Jul;50(1):77-85.@@Authors unspecified: Safinamide: FCE 26743, NW 1015, PNU 151774, PNU 151774E. Drugs R D. 2004;5(6):355-8. |
| Groups | Approved; Investigational |
| Direct Classification | Alpha amino acid amides |
| SMILES | C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL396778 |
